Offikuf LS Junior Oral Suspension
By Offikuf LS
Rx
60ml Oral Suspension in a Bottle

Composition
Levosalbutamol(0.5mg/5ml) + Ambroxol(15mg/5ml) + Guaifenesin(50mg/5ml)

Manufacturer - Fibovil Pharmaceuticals Pvt Ltd
Plot No. 398, Industrial Area, Phase-1, Panchkula 134113

Expires on or after
September, 2025

liver
Offikuf LS Junior Oral Suspension should be handled cautiously in individuals with liver disease. It may be necessary to adjust the dosage of Offikuf LS Junior Oral Suspension for these patients. Due to limited available data, it is recommended to consult with your doctor about the use of Offikuf LS Junior Oral Suspension if you have liver issues.

kidney
Offikuf LS Junior Oral Suspension may require dose adjustment in patients with kidney disease. Limited information is available. Consult your doctor for guidance.

alcohol
Offikuf LS Junior Oral Suspension can increase drowsiness when consumed with alcohol. It is important to be cautious about this effect.

driving
Offikuf LS Junior Oral Suspension may cause side effects that can impair driving.

pregnancy
Offikuf LS Junior Oral Suspension may not be safe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Always consult your doctor regarding use during pregnancy.

breastfeeding
Offikuf LS Junior Oral Suspension is likely safe for breastfeeding mothers. Limited data shows no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹69
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025